These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29278418)

  • 1. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of CpG island promoters in uveal melanoma.
    Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
    Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
    Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
    Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
    Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
    Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
    Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
    Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
    de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
    Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
    Roh MR; Gupta S; Park KH; Chung KY; Lauss M; Flaherty KT; Jönsson G; Rha SY; Tsao H
    J Invest Dermatol; 2016 May; 136(5):1002-1011. PubMed ID: 26854490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
    Liu S; Ren S; Howell P; Fodstad O; Riker AI
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.
    Thomas NE; Slater NA; Edmiston SN; Zhou X; Kuan PF; Groben PA; Carson CC; Hao H; Parrish E; Moschos SJ; Berwick M; Ollila DW; Conway K
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1097-105. PubMed ID: 24986547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
    Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
    J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
    Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
    Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
    J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island methylation profiling in human melanoma cell lines.
    Tellez CS; Shen L; Estécio MR; Jelinek J; Gershenwald JE; Issa JP
    Melanoma Res; 2009 Jun; 19(3):146-55. PubMed ID: 19441164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation characteristics of primary melanomas with distinct biological behaviour.
    Ecsedi S; Hernandez-Vargas H; Lima SC; Vizkeleti L; Toth R; Lazar V; Koroknai V; Kiss T; Emri G; Herceg Z; Adany R; Balazs M
    PLoS One; 2014; 9(5):e96612. PubMed ID: 24832207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.